| pubmed-article:19043922 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19043922 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
| pubmed-article:19043922 | lifeskim:mentions | umls-concept:C0019699 | lld:lifeskim |
| pubmed-article:19043922 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19043922 | lifeskim:mentions | umls-concept:C0012655 | lld:lifeskim |
| pubmed-article:19043922 | lifeskim:mentions | umls-concept:C0063690 | lld:lifeskim |
| pubmed-article:19043922 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:19043922 | lifeskim:mentions | umls-concept:C1871526 | lld:lifeskim |
| pubmed-article:19043922 | lifeskim:mentions | umls-concept:C1456706 | lld:lifeskim |
| pubmed-article:19043922 | lifeskim:mentions | umls-concept:C1963724 | lld:lifeskim |
| pubmed-article:19043922 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:19043922 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:19043922 | pubmed:dateCreated | 2008-12-2 | lld:pubmed |
| pubmed-article:19043922 | pubmed:abstractText | HIV type-1 (HIV-1) protease (PR), reverse transcriptase (RT) and integrase (IN) share the same precursor polyprotein and there is much evidence to suggest functional interactions between IN and RT. We aimed to elucidate whether long-term highly active antiretroviral therapy (HAART) targeting PR and RT could influence raltegravir susceptibility and the fitness of IN. | lld:pubmed |
| pubmed-article:19043922 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19043922 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19043922 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19043922 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19043922 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19043922 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19043922 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19043922 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19043922 | pubmed:issn | 1359-6535 | lld:pubmed |
| pubmed-article:19043922 | pubmed:author | pubmed-author:CabreraCecili... | lld:pubmed |
| pubmed-article:19043922 | pubmed:author | pubmed-author:ClotetBonaven... | lld:pubmed |
| pubmed-article:19043922 | pubmed:author | pubmed-author:Martinez-Pica... | lld:pubmed |
| pubmed-article:19043922 | pubmed:author | pubmed-author:RuizLidiaL | lld:pubmed |
| pubmed-article:19043922 | pubmed:author | pubmed-author:MarfilSilviaS | lld:pubmed |
| pubmed-article:19043922 | pubmed:author | pubmed-author:GarciaElisabe... | lld:pubmed |
| pubmed-article:19043922 | pubmed:author | pubmed-author:BuzónMaria... | lld:pubmed |
| pubmed-article:19043922 | pubmed:author | pubmed-author:PuertasMaria... | lld:pubmed |
| pubmed-article:19043922 | pubmed:author | pubmed-author:BlancoJulìaJ | lld:pubmed |
| pubmed-article:19043922 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19043922 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:19043922 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19043922 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19043922 | pubmed:pagination | 881-93 | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:meshHeading | pubmed-meshheading:19043922... | lld:pubmed |
| pubmed-article:19043922 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:19043922 | pubmed:articleTitle | Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy. | lld:pubmed |
| pubmed-article:19043922 | pubmed:affiliation | IrsiCaixa Foundation, Institut de Recerca en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain. | lld:pubmed |
| pubmed-article:19043922 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19043922 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19043922 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19043922 | lld:pubmed |
